Change over period: —
NSE · RAINBOW
RAINBOW
-21.3% from the 52-week high · +14.0% above the low
Rainbow Children's Medicare Ltd. operates multi-specialty pediatric and obstetrics & gynecology hospitals. The company is headquartered in Hyderabad, Telangana and currently employs 3,581 full-time employees. The company went IPO on 2022-05-10. The firm is a multi-specialty pediatric, and obstetrics and gynecology hospital operating over 16 hospitals and three clinics in six cities, with a total bed capacity of approximately 1,655 beds. The company offers pediatric services under Rainbow Children’s Hospital, which include newborn and pediatric intensive care, pediatric multi-specialty services and pediatric quaternary care (including multi-organ transplants). Its women care services under Birthright by Rainbow that offers perinatal care services which includes normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care along with gynecology services. The company also operates pediatric DNB training programs in private healthcare, offering post graduate residential DNB and fellowship programs. The company also provides a Rainbow Children’s Hospital mobile application.
The short version. RAINBOW reported revenue of ₹548 crore for Sep 2026, up 23.1% from a year earlier. Net profit was ₹82 crore (up 9.3% year on year). Return on equity was 16.9% in Mar 2026. Promoter holding was 49.83% in Sep 2026, down 0.02 points over 8 quarters.
1 · The price
How has the stock traded?
RAINBOW trades 21.3% below its 52-week high and 14.0% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹548 cr.
Sep 2026 net profit of ₹82 cr.
1.9 pts lower than a year earlier.
Revenue compounded at 13.2% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 548 | 470 | 460 | 445 | 445 | 353 | 370 | 398 |
| Net profit | 82 | 61 | 77 | 73 | 75 | 53 | 56 | 69 |
| Net margin % | 15.0 | 12.9 | 16.8 | 16.3 | 16.9 | 15.2 | 15.2 | 17.3 |
| EPS (₹) | 8.08 | 5.96 | 7.59 | 7.14 | 7.41 | 5.27 | 5.55 | 6.76 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 1703 | 1516 | 1297 | 1174 | 974 |
| Net profit | 278 | 243 | 217 | 211 | 138 |
| Net margin % | 16.3 | 16.1 | 16.7 | 18.0 | 14.2 |
| EPS (₹) | 27.41 | 23.97 | 21.38 | 20.77 | 13.62 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 16.9% in Mar 2026; debt to equity is 0.00.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 16.9 | 16.6 | 17.2 | 19.9 |
| Return on capital % | 16.8 | 18.1 | 17.5 | 20.6 |
| EBITDA margin % | 33.6 | 34.5 | 34.9 | 35.5 |
| Net margin % | 15.9 | 15.5 | 16.3 | 17.5 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 13.2% | — |
| Profit CAGR | 9.7% | — |
4 · The owners
Who holds it, and are they adding?
Down 0.02 pts over 8 quarters.
Down 10.46 pts over 8 quarters.
Up 9.41 pts over 8 quarters.
+21 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 49.85 | 49.85 | 49.85 | 49.85 | 49.84 | 49.84 | 49.84 | 49.83 | -0.02 |
| FII | 25.12 | 23.69 | 23.59 | 21.85 | 19.23 | 17.24 | 16.03 | 14.66 | -10.46 |
| DII | 13.87 | 15.31 | 15.44 | 17.46 | 19.49 | 21.13 | 22.56 | 23.28 | +9.41 |
| Public | 11.16 | 11.14 | 11.11 | 10.84 | 11.4 | 11.67 | 11.39 | 11.83 | +0.67 |
Mutual fund holdings · Oct 2026
115 schemes hold this stock
94 the month before.
- TATA INDIA PHARMA & HEALTHCARE FUND4.02% of NAV
- NJ ELSS Tax Saver Fund3.31% of NAV
- Groww BSE Hospitals ETF2.85% of NAV
- Bandhan Healthcare Fund2.81% of NAV
- MOTILAL OSWAL SMALL CAP FUND2.35% of NAV
- Shriram Multi Sector Rotation Fund2.33% of NAV
- LIC MF HEALTHCARE FUND2.12% of NAV
- Navi Flexi Cap Fund2.09% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for RAINBOW are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about RAINBOW
What is the RAINBOW share price?
RAINBOW (RAINBOW) last closed at ₹1,243.30, down 1.17% on the day. Its 52-week range is ₹1,103.80 to ₹1,598.60.
What is the market cap of RAINBOW?
RAINBOW has a market capitalisation of about ₹12,773 crore. Its price-to-earnings ratio is 43.7.
How are RAINBOW's latest results?
RAINBOW reported revenue of ₹548 crore for Sep 2026, up 23.1% from a year earlier. Net profit was ₹82 crore (up 9.3% year on year). Return on equity was 16.9% in Mar 2026. Promoter holding was 49.83% in Sep 2026, down 0.02 points over 8 quarters.
Who owns RAINBOW?
As of Sep 2026, shareholding was: Promoter 49.83%, FII 14.66%, DII 23.28%, Public 11.83%.
How many mutual funds hold RAINBOW?
115 mutual fund schemes held RAINBOW in October 2026. That compares with 94 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 27 Jun 2025 · Final Dividend - Rs. 3
- 23 Jul 2024 · Final Dividend - Rs. 3
- 22 Jun 2023 · Final Dividend - Rs. 3
- 07 Sep 2022 · Final Dividend - Rs. 2
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.